CTRP3 alleviated oxidized (ox)-LDL-induced inflammation and endothelial dysfunction by activating the phosphoinositide 3-kinase (PI3K)/Akt/endothelial nitric oxide synthase (eNOS) pathway (23). Here, AKT1 is linked to endothelial dysfunction.